W
02269
Wuxi Biologics (Cayman)
31.080
+1.140+3.81%Closed16:08 06/12 HKT
OPEN/PREV CLOSE31.180/31.080
TODAY RANGE30.780-31.560
VOL15.93M
MARKET CAP128.09B
52 WEEK RANGE23.100-44.000
AVG VOL (3M)29.57M
% TURNOVER0.38%
TURNOVER495.31M
P/E (TTM)23.571
% RANGE2.51%
EPS(TTM)1.312
P/E(FORWARD)20.269
P/B2.449
BVPS12.628
DIVIDEND--
P/S5.309
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP128.09B
SHARES OUTSTANDING4.14B
NEXT EARNINGS08/17-08/21
FREE FLOAT4.14B
LOT SIZE500
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
WuXi Biologics (SEHK:2269) Stock After Regulatory Jitters And A 76.5% Five Year Slide
Simply Wall St·06/06 20:24
Assessing WuXi Biologics (SEHK:2269) Valuation After Its Recent Share Price Momentum Shift
Simply Wall St·06/05 17:29
Is WuXi Biologics (SEHK:2269) Offering Value After Its Recent Share Price Recovery?
PR Newswire·06/05 02:45
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
PUBT·06/04 13:50
BioDlink proposes auditor switch to Deloitte from PwC
PUBT·06/04 13:49
TOT Biopharm proposes Deloitte as new auditor as PwC retires
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.